PharmaCyte Biotech Intangible Assets

PharmaCyte Biotech (PMCB) currently reports a intangible assets of $1.5M as of January 2026. That compares with $1.5M in the prior-year period — up 0.0% year over year. Use the charts on this page to explore PharmaCyte Biotech's intangible assets history and peer comparisons.

PharmaCyte Biotech's intangible assets was unchanged from $1.5M to $1.5M — essentially flat versus a year earlier (period ending January 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

PharmaCyte Biotech reported $1.5M in intangible assets as of January 2026. That compares with $1.5M in the prior-year period — up 0.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current intangible assets of $1.5M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for PharmaCyte Biotech, and consider following PMCB for alerts when major investors trade the stock.

PharmaCyte Biotech is classified in the Healthcare sector. On intangible assets, it currently shows $1.5M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing PMCB with unrelated industries.